Susanna Chyu
Psychiatry · Orlando, FLNPI 1235180803
Payments from drug & device makers
Across 224 payments — averaging $206.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tris Pharma Inc$45K
- Johnson & Johnson$306
- AbbVie$264
- Sunovion Pharmaceuticals Inc.$253
- Otsuka America Pharmaceutical, Inc.$97
- Neos Therapeutics, LP$81
- plus $454 from 13 others
What the payments were for
- Speaking & faculty fees$33,00071%
- Travel & lodging$8,63919%
- Food & beverage$4,64810%
- Gifts$220%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tris Pharma Inc | 144 | $44,854 |
| Johnson & Johnson | 14 | $306 |
| AbbVie(2 entities) | 11 | $264 |
| Sunovion Pharmaceuticals Inc. | 17 | $253 |
| Otsuka America Pharmaceutical, Inc. | 5 | $97 |
| Neos Therapeutics, LP | 5 | $81 |
| Bausch Health US, LLC | 4 | $67 |
| Supernus Pharmaceuticals, Inc. | 3 | $60 |
| Alkermes, Inc. | 3 | $57 |
| Ironshore Pharmaceuticals Inc. | 3 | $56 |
| Validus Pharmaceuticals LLC | 5 | $56 |
| Corium, LLC | 2 | $41 |
| Eisai Inc. | 2 | $28 |
| Lundbeck LLC | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Shire North American Group Inc | 1 | $14 |
| Neuronetics, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Dyanavel XR$42,266
- Quillichew ER$22,442
- Quillivant$16,477
- Quillivant XR$5,965
- SPRAVATO$103
How this compares
$46,309 in reported general payments places this provider in the 90th percentile of 2,059 psychiatry providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 16 | $431 |
| Alprazolam | 24 | $207 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Orlando
- Linda HarperOrlando$8.5M
- Morteza NadjafiOrlando$5.3M
- David MedinaOrlando$1.1M
- Edwin GomezWeston$24.9M
- Rishi KakarTamarac$23.9M
- Peter VentreOakland Park$18.7M
- Jose GamezHialeah$14.8M
- John JoyceJacksonville$13.6M
- Silvia Silva-DulucMiami$11.7M
- Kelley WilsonTampa$11.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.